Basic Research published in #ASNJASN identified a protein called ARL13B that helps drive cyst growth in PKD. In mice, blocking this protein reduced cyst growth and improved kidney health, suggesting it could be a possible target for future treatments. kidney.pub/JASN1238 @vansciver.bsky.social
October 6, 2026 at 5:30 PM
Basic Research published in #ASNJASN identified a protein called ARL13B that helps drive cyst growth in PKD. In mice, blocking this protein reduced cyst growth and improved kidney health, suggesting it could be a possible target for future treatments. kidney.pub/JASN1238 @vansciver.bsky.social
Authors review the breakthroughs in kidney xenotransplantation in the past few decades and highlight the outstanding immunologic hurdles in a JASN "Mechanisms of Kidney Diseases" article. https://bit.ly/JASN0745
#ASNJASN
#ASNJASN
May 9, 2025 at 7:00 PM
Authors review the breakthroughs in kidney xenotransplantation in the past few decades and highlight the outstanding immunologic hurdles in a JASN "Mechanisms of Kidney Diseases" article. https://bit.ly/JASN0745
#ASNJASN
#ASNJASN
Furosemide versus torsemide: May the highest dose win! Authors glean insights from the TRANSFORM-HF trial. bit.ly/KN1704-08
#ASNKidneyNews
#ASNJASN
#ASNKidneyNews
#ASNJASN
April 16, 2025 at 4:23 PM
Furosemide versus torsemide: May the highest dose win! Authors glean insights from the TRANSFORM-HF trial. bit.ly/KN1704-08
#ASNKidneyNews
#ASNJASN
#ASNKidneyNews
#ASNJASN
New integrated approach identified candidate genes with diabetes-specific effects on kidney function, advancing the understanding of DKD pathophysiology. https://bit.ly/JASN0718
#ASNJASN
#BasicResearch
#GeneticResearch
@ksusztak.bsky.social
#ASNJASN
#BasicResearch
#GeneticResearch
@ksusztak.bsky.social
June 6, 2025 at 3:30 PM
New integrated approach identified candidate genes with diabetes-specific effects on kidney function, advancing the understanding of DKD pathophysiology. https://bit.ly/JASN0718
#ASNJASN
#BasicResearch
#GeneticResearch
@ksusztak.bsky.social
#ASNJASN
#BasicResearch
#GeneticResearch
@ksusztak.bsky.social
High-intensity interval training significantly reduced the risk of rapid eGFR decline in older adults. https://bit.ly/JASN0636
#ASNJASN
@knutarl.bsky.social
#ASNJASN
@knutarl.bsky.social
March 8, 2025 at 4:00 PM
High-intensity interval training significantly reduced the risk of rapid eGFR decline in older adults. https://bit.ly/JASN0636
#ASNJASN
@knutarl.bsky.social
#ASNJASN
@knutarl.bsky.social
Now live in #ASNJASN, simultaneously published with #KidneyWk: "Immunosuppression in Older Kidney Transplant Recipients: A Randomized Controlled Trial"
Read more: kidney.pub/JASN0924
Read more: kidney.pub/JASN0924
November 7, 2025 at 5:30 PM
Now live in #ASNJASN, simultaneously published with #KidneyWk: "Immunosuppression in Older Kidney Transplant Recipients: A Randomized Controlled Trial"
Read more: kidney.pub/JASN0924
Read more: kidney.pub/JASN0924
In a new "Mechanisms of Kidney Disease" article in #ASNJASN, authors explore population studies and the genetic architecture of kidney diseases, highlighting a spectrum of risk. Read more: kidney.pub/JASN0893
@dannygale.bsky.social
@dannygale.bsky.social
October 13, 2025 at 8:00 PM
In a new "Mechanisms of Kidney Disease" article in #ASNJASN, authors explore population studies and the genetic architecture of kidney diseases, highlighting a spectrum of risk. Read more: kidney.pub/JASN0893
@dannygale.bsky.social
@dannygale.bsky.social
What are the latest insights on treating hepatorenal syndrome? Read this #ASNJASN Clinical Nephrology Insight article: kidney.pub/JASN0920
December 30, 2025 at 4:00 PM
What are the latest insights on treating hepatorenal syndrome? Read this #ASNJASN Clinical Nephrology Insight article: kidney.pub/JASN0920
This prospective study in #ASNJASN of 976 adults measured the association between subclinical primary aldosteronism and kidney outcomes. Read more: kidney.pub/JASN1039 Rémi Goupil
February 22, 2026 at 3:00 PM
This prospective study in #ASNJASN of 976 adults measured the association between subclinical primary aldosteronism and kidney outcomes. Read more: kidney.pub/JASN1039 Rémi Goupil
New in #ASNJASN: This #perspective dives deep on the hyperfiltration paradigm, suggesting the integration of nephro-podometrics to enrich its explanatory power for CKD.
kidney.pub/JASN0852
kidney.pub/JASN0852
September 20, 2025 at 4:00 PM
New in #ASNJASN: This #perspective dives deep on the hyperfiltration paradigm, suggesting the integration of nephro-podometrics to enrich its explanatory power for CKD.
kidney.pub/JASN0852
kidney.pub/JASN0852
Research suggests Clonal hematopoiesis of indeterminate potential (CHIP) may contribute to CKD and its comorbidities, necessitating additional research. https://bit.ly/JASN0739
@drflashheart.bsky.social
@pnatarajanmd.bsky.social
@zhiyu.bsky.social
#ASNJASN
@drflashheart.bsky.social
@pnatarajanmd.bsky.social
@zhiyu.bsky.social
#ASNJASN
May 15, 2025 at 6:00 PM
Research suggests Clonal hematopoiesis of indeterminate potential (CHIP) may contribute to CKD and its comorbidities, necessitating additional research. https://bit.ly/JASN0739
@drflashheart.bsky.social
@pnatarajanmd.bsky.social
@zhiyu.bsky.social
#ASNJASN
@drflashheart.bsky.social
@pnatarajanmd.bsky.social
@zhiyu.bsky.social
#ASNJASN
The HiLo pragmatic, multicenter randomized trial, compared a higher ("Hi") versus lower ("Lo") serum phosphate target in patients undergoing maintenance hemodialysis. Read more about what researchers learned from the trial: kidney.pub/JASN0765 #ASNJASN
July 31, 2025 at 3:00 PM
The HiLo pragmatic, multicenter randomized trial, compared a higher ("Hi") versus lower ("Lo") serum phosphate target in patients undergoing maintenance hemodialysis. Read more about what researchers learned from the trial: kidney.pub/JASN0765 #ASNJASN
How Does Dietary Potassium Influence Blood Pressure? Check out this #ASNJASN Mechanisms of Kidney Disease article: kidney.pub/JASN0988
December 15, 2025 at 7:00 PM
How Does Dietary Potassium Influence Blood Pressure? Check out this #ASNJASN Mechanisms of Kidney Disease article: kidney.pub/JASN0988
Authors of #ASNJASN #perspective propose a more individualized approach to treating severe hyponatremia, arguing that sodium correction rates should be tailored to patient-specific risks rather than governed by strict universal limits. kidney.pub/JASN1270 @sagarnigs.bsky.social
October 1, 2026 at 4:15 PM
Authors of #ASNJASN #perspective propose a more individualized approach to treating severe hyponatremia, arguing that sodium correction rates should be tailored to patient-specific risks rather than governed by strict universal limits. kidney.pub/JASN1270 @sagarnigs.bsky.social
The findings of this study highlight the substantial and growing Cardiovascular-Kidney-Metabolic (CKM) syndrome-related burden, emphasizing the urgent need for comprehensive and targeted interventions. https://bit.ly/JASN0658
#ASNJASN
#ASNJASN
March 22, 2025 at 2:00 PM
The findings of this study highlight the substantial and growing Cardiovascular-Kidney-Metabolic (CKM) syndrome-related burden, emphasizing the urgent need for comprehensive and targeted interventions. https://bit.ly/JASN0658
#ASNJASN
#ASNJASN
#Review in #ASNJASN: Human-based kidney models could improve drug safety testing, reduce animal use, and help researchers develop better treatments for kidney disease. kidney.pub/JASN1272 @azeloglu.bsky.social
October 8, 2026 at 6:30 PM
#Review in #ASNJASN: Human-based kidney models could improve drug safety testing, reduce animal use, and help researchers develop better treatments for kidney disease. kidney.pub/JASN1272 @azeloglu.bsky.social
This #ASNJASN research explored how two transcription factors, Dmrt2 and Hmx2, influence the differentiation of intercalated cells in the kidney, which are crucial for acid-base balance. Read more: kidney.pub/JASN0885 #BasicScience
December 4, 2025 at 3:00 PM
This #ASNJASN research explored how two transcription factors, Dmrt2 and Hmx2, influence the differentiation of intercalated cells in the kidney, which are crucial for acid-base balance. Read more: kidney.pub/JASN0885 #BasicScience
Study demonstrates that the clinical definition of scleroderma renal crisis encompassed heterogeneity in the patterns of kidney injury. kidney.pub/JASN0720
#ASNJASN
@njourde.bsky.social
#ASNJASN
@njourde.bsky.social
June 15, 2025 at 3:59 PM
Study demonstrates that the clinical definition of scleroderma renal crisis encompassed heterogeneity in the patterns of kidney injury. kidney.pub/JASN0720
#ASNJASN
@njourde.bsky.social
#ASNJASN
@njourde.bsky.social
Discussing peer review, Manuel Praga, MD, noted “the work of a reviewer for high-quality scientific journals like JASN is crucial for maintaining high standards of rigor, quality, originality, and independence. These values are even more essential today.” Top 5 #ASNJASN reviewer 2026. #PRW2026
October 5, 2026 at 3:04 PM
Genetic regulation of plasma sodium concentration is variable and pathways involving the pituitary gland have an important role. There is no evidence of genetic predisposition for the plasma sodium-lowering effect of thiazides. bit.ly/JASN0622
#ASNJASN
#BasicResearch
#ASNJASN
#BasicResearch
March 1, 2025 at 2:45 PM
Genetic regulation of plasma sodium concentration is variable and pathways involving the pituitary gland have an important role. There is no evidence of genetic predisposition for the plasma sodium-lowering effect of thiazides. bit.ly/JASN0622
#ASNJASN
#BasicResearch
#ASNJASN
#BasicResearch
The April issue of JASN is now available online! Topics covered this month include:
- Novel Therapies for IgA Nephropathy
- Rituximab in Podocytopathies
- and more
Find the issue here: journals.lww.com/jas...
#ASNJASN
- Novel Therapies for IgA Nephropathy
- Rituximab in Podocytopathies
- and more
Find the issue here: journals.lww.com/jas...
#ASNJASN
April 1, 2025 at 4:30 PM
The April issue of JASN is now available online! Topics covered this month include:
- Novel Therapies for IgA Nephropathy
- Rituximab in Podocytopathies
- and more
Find the issue here: journals.lww.com/jas...
#ASNJASN
- Novel Therapies for IgA Nephropathy
- Rituximab in Podocytopathies
- and more
Find the issue here: journals.lww.com/jas...
#ASNJASN
Cystatin C is a more informative marker of kidney function than creatinine alone. Combining creatinine and cystatin C provides the most accurate assessment of kidney function and patient risk. Wider adoption is limited by test availability. kidney.pub/JASN1201?... #ASNJASN
August 10, 2026 at 7:31 PM
Cystatin C is a more informative marker of kidney function than creatinine alone. Combining creatinine and cystatin C provides the most accurate assessment of kidney function and patient risk. Wider adoption is limited by test availability. kidney.pub/JASN1201?... #ASNJASN
High or low BMI may influence the accuracy of eGFR. This #ASNJASN study finds indexed eGFRcr-cys to be more accurate than eGFRcr or eGFRcys across the BMI spectrum, improving GFR classification and treatment decisions. kidney.pub/JASN0760 @alexchangmd.bsky.social
July 8, 2025 at 7:00 PM
High or low BMI may influence the accuracy of eGFR. This #ASNJASN study finds indexed eGFRcr-cys to be more accurate than eGFRcr or eGFRcys across the BMI spectrum, improving GFR classification and treatment decisions. kidney.pub/JASN0760 @alexchangmd.bsky.social
Treatment with tirzepatide in people with obesity or overweight and/or type 2 diabetes was associated with preserved kidney function. kidney.pub/JASN0764 #ASNJASN
June 24, 2025 at 5:00 PM
Treatment with tirzepatide in people with obesity or overweight and/or type 2 diabetes was associated with preserved kidney function. kidney.pub/JASN0764 #ASNJASN
New in #ASNJASN and at #Hypertension25: In a randomized, double-blind, placebo-controlled trial, Baxdrostat reduced systolic blood pressure in patients with CKD and uncontrolled hypertension. Read more about its safety and efficacy in patients with CKD here: kidney.pub/JASN0849
September 6, 2025 at 2:00 PM
New in #ASNJASN and at #Hypertension25: In a randomized, double-blind, placebo-controlled trial, Baxdrostat reduced systolic blood pressure in patients with CKD and uncontrolled hypertension. Read more about its safety and efficacy in patients with CKD here: kidney.pub/JASN0849